Federica Ungaro

Jul 30, 2024 | mdpi.com | Francesca Bernardi |Federica Ungaro |Ferdinando D’Amico |Alessandra Zilli

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 22, 2023 | mdpi.com | Maria Cristina Napolitano |Ernesto Fasulo |Federica Ungaro |Luca Massimino

1. IntroductionIrritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits, either in stool form or frequency, persisting for at least 6 months in the absence of an identifiable organic pathology [].

May 23, 2023 | drugtargetreview.com | Federica Ungaro |Maria Hayes |Dorit Avni |Kiron Viswanath

An increasing number of people worldwide suffer from inflammatory bowel disease (IBD). However, no treatment is effective for all patients. In this article, researchers working on the Algae4IBD project explain how algae may represent a valuable source of prebiotics and new therapeutic agents for IBD and other diseases.